Segment Information (Tables)

3 Months Ended

Sep. 30, 2012

Segment Reporting [Abstract]

Revenue by Reportable Segment

The following table includes revenue for each reportable segment and reconciling items necessary to agree to amounts reported in the condensed consolidated statements of earnings:

	Three Months Ended September 30,
(in millions)	2012			2011
Pharmaceutical	$	23,498		$	24,418
Medical	2,393			2,380
Total segment revenue	25,891			26,798
Corporate (1)	(2		)	(6		)
Total revenue	$	25,889		$	26,792

(1) Corporate revenue consists of the elimination of inter-segment revenue.

Segment Profit by Reportable Segment

The following table includes segment profit by reportable segment and reconciling items necessary to agree to amounts reported in the condensed consolidated statements of earnings:

	Three Months Ended September 30,
(in millions)	2012			2011
Pharmaceutical	$	400		$	363
Medical	74			79
Total segment profit	474			442
Corporate	(17		)	(30		)
Total operating earnings	$	457		$	412